Genenta signs Definitive Agreements with Sophia High Tech
Rhea-AI Summary
Genenta (Nasdaq: GNTA) signed definitive agreements to invest a total of €6.0 million in Sòphia High Tech in two tranches to acquire a 19.9% stake after tranche one and a 51% majority stake after tranche two.
Sòphia HT reported 2024 revenues of ~€6.29 million and EBITDA of ~€0.96 million, expects ~€8 million sales for 2025, and projects roughly doubling 2024 revenue and growing headcount from 44 to ~70 by 2027. Proceeds will fund capacity scale‑up, insourcing, automation, and commercial expansion.
Positive
- €6.0M investment committed in two tranches
- Majority control to reach 51% after second tranche
- 2024 revenue €6.29M with EBITDA ≈ €0.96M
- 2025 preliminary sales ≈ €8M (internal figures)
- Target to double revenue from 2024 levels by 2027 and increase headcount to ~70
Negative
- None.
News Market Reaction – GNTA
In the Apr 23 session, GNTA declined 1.69%, reflecting a mild negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 27 | Sòphia HT binding offer | Positive | -14.3% | Announced binding offer to fund EUR 6.0M for potential controlling stake in Sòphia HT. |
| Mar 24 | Biotech platform options | Positive | +8.2% | Outlined evolution into Saentra Forge and exploration of collaborations for original biotech platform. |
| Mar 13 | CEO board appointment | Positive | +1.7% | CEO appointed to Board of Guarantors of the Italian Academy at Columbia University. |
| Feb 27 | Transformation progress | Positive | +3.2% | Advanced Saentra Forge transformation, added ATC board member, and highlighted upcoming GBM trial publication. |
| Jan 27 | Strategic transformation | Positive | +18.5% | Announced shift into industrial consolidator model and staged acquisition funding for ATC. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent GNTA news has mostly seen positive price reactions, with only the prior Sòphia High Tech binding-offer headline drawing a sharp negative move despite a strategic pivot theme.
Over the last few months, GNTA has reported a series of announcements tied to its transformation into an industrial consolidator in biotech, defense, aerospace, and national-security technologies. Key milestones include the Jan 27 strategic transformation and ATC funding plan, governance and consolidation updates on Feb 27, and CEO recognition on Mar 13. On Mar 24, management detailed ongoing evaluation of options for its legacy biotech platform, and on Mar 27 it disclosed a binding offer for up to 51% of Sòphia High Tech. Today’s definitive agreements formalize that previously announced trajectory.
Key Terms
EBITDA financial
capex financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Genenta enters aerospace as it continues its strategic transformation into a next-generation industrial consolidator
MILAN,Italy, April 23, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian national-security-related technologies, today announced that it has signed definitive agreements2 with Sòphia High Tech S.r.l., (Sòphia HT) an Italian company manufacturing critical parts for Europe's space and defense programs.
Genenta expects to fund a total of
Sòphia HT joins Genenta with a solid net cash position and an already profitable operating profile. In its latest filed financial statements for fiscal year 2024, Sòphia HT reported3 total revenues and other operating income of approximately
Sòphia High Tech is an aerospace and defense engineering and manufacturing company, headquartered in Somma Vesuviana (Naples), Italy. Since its founding in 2013, Sòphia HT has grown from a specialized engineering boutique into a recognized European aerospace manufacturer, employing a team of more than 40 engineers, PhD researchers, and skilled technical specialists. Sòphia HT focuses on the design, simulation, prototyping, manufacturing, testing, and qualification of precision mechanical components and assemblies for space, defense, and advanced industrial applications. With over 530 advanced projects completed, Sòphia HT serves leading European aerospace and defense organizations, including the European Space Agency, Italian Aerospace Agency, AVIO, Thales Alenia Space, Leonardo, MBDA, GSSI, and D-Orbit, and also prestigious automotive brands such as Lamborghini.
This transaction reflects the broader strategic transformation discussed by our CEO, Pierluigi Paracchi, in a recent episode of Economic Security Watch, the new podcast from fDi Intelligence, a Financial Times company, where he joined Danielle Myles to discuss Genenta’s evolution from biotech into a strategic consolidator active across Italy’s national security sectors. The interview is available here: https://www.fdiintelligence.com/video/70c2aff3-7336-4496-956f-30ff7ae5c582
About Genenta Science
Genenta Science (Nasdaq: GNTA) is evolving into a next-generation strategic consolidator focused on privately held specialized companies operating in Italian national security-regulated sectors, with activities spanning cybersecurity, defense, aerospace, and biotechnology/biosecurity.
About Sòphia High Tech
Sòphia High Tech S.r.l. is an Italian aerospace and defense engineering and manufacturing company. At its core, Sòphia builds the critical mechanical components of space and defense systems — the precision parts that hold rockets together, protect satellites in orbit, and allow aircraft to perform under extreme stress. The company covers the entire product lifecycle, from initial concept design and computer simulation, through prototyping and manufacturing, all the way to final testing, assembly, and qualification for flight. What sets Sòphia apart is its mastery of advanced manufacturing techniques — including state-of-the-art metal 3D printing (known as Selective Laser Melting), CNC precision machining and multitasking, and the ability to work with some of the most demanding exotic materials in the industry, including titanium, Inconel, tungsten, and specialized copper alloys. The company also conducts original materials research — developing entirely new metallic blends tailored to the specific demands of space propulsion. Certified to the EN9100 aerospace quality standard and to ECSS-Q-ST-70-80C, the ESA specification for additive manufacturing, Sòphia is one of the very few companies in Europe qualified to 3D-print flight-ready space hardware to ESA and NASA standards. With over 530 advanced projects completed, Sòphia serves leading European aerospace and defense organizations, including ESA, AVIO, Thales Alenia Space, Leonardo, MBDA, GSSI, and D-Orbit.
Non-GAAP Information. This release includes EBITDA, which is a non-GAAP financial measure. EBITDA is defined as net loss adjusted to exclude interest income, income tax expense, and depreciation and amortization. This non-GAAP measure is not in accordance with, or an alternative for, measures prepared in accordance with generally accepted accounting principles (GAAP) and may be different from non-GAAP measures used by other companies. In addition, this non-GAAP measure is not based on any comprehensive set of accounting rules or principles. Genenta believes that this non-GAAP financial measure, when considered together with financial information prepared in accordance with GAAP, can enhance investors’ and analysts’ ability to meaningfully compare financial results from period to period and to forward-looking guidance, and to identify operating trends in the business. However, non-GAAP information is not superior to financial measures calculated in accordance with GAAP, is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.
Forward-Looking Statements. Statements in this press release contain “forward-looking statements,” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “suggest,” “target,” “aim,” “should,” "will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Genenta’s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict, including risks related to the transition to Saentra Forge, ability to close the transaction with Sòphia High Tech, financial forecasts of Sòphia High Tech, and expected use of proceeds of Sòphia High Tech, etc.. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in Genenta's Annual Report on Form 20-F for the year ended December 31, 2024, and Genenta's material disclosures on Form 6-K dated October 10, 2025, as well as other Form 6-K disclosures filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of the date of this announcement, and Genenta undertakes no duty to update such information except as required under applicable law.
Genenta Science Media
Tiziana Pollio, Mobile: +39 348 23 15 143
email: tiziana.pollio@genenta.com
1 The name change from Genenta Science S.p.A. to Saentra Forge S.p.A. is subject to shareholder approval.
2 The transaction will be subject, among other conditions, to the condition precedent relating to obtaining clearance from the Italian Presidency of the Council of Ministers.
3 The historical and current financial statements of Sophia HT are unaudited.
